2,605 KRYS shares were withheld to cover taxes or exercise cost (CEO) | OQRO Insider tradesWhy it stands out
Routine share withholding; mechanical by default.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Feb 27, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Mar 3, 2026
CEOTax withholding
Context
- Classification
tax withholding
Code F — shares delivered to pay exercise price or tax liability
- Planned / mechanical clue
Tax mechanics (code F)
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001298709-26-000002
Added to OQROOct 6, 2026, 7:59 PM UTC Data qualityVerified: identifiers matched exactly IssuerKrystal Biotech, Inc. Reporting personKrish S Krishnan RelationshipDirector, Officer, 10% owner Officer titlePresident and CEO TableNon-derivative (Table I) Transaction dateFeb 27, 2026 Acquired / disposedDisposed (D) Shares owned after1,500,253 Footnotes from the filing
- Represents the number of shares of common stock surrendered to the Company for tax withholding upon the vesting of 5,725 RSUs on February 27, 2026.
- The closing price on February 27, 2026 of the Company's common stock on the Nasdaq Global Select Market.